Your browser doesn't support javascript.
loading
Proactive treatment of angiotensin receptor antibodies in kidney transplantation with plasma exchange and/or candesartan is safe and associated with excellent graft survival at 4 years: A single centre Australian experience.
Carroll, Robert P; Deayton, Sue; Emery, Timothy; Munasinghe, Watsala; Tsiopelas, Eleni; Fleet, Adrian; Lake, Meg; Humphreys, Ian; Jalalonmuhali, Maisarah; Coates, Patrick.
Afiliación
  • Carroll RP; South Australian Tissue Typing and Immunogenetics Service, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia; Central Northern Adelaide Renal and Transplantation Services (CNARTS), Royal Adelaide Hospital, Adelaide, South Australia, Australia. Electronic address: Rober
  • Deayton S; South Australian Tissue Typing and Immunogenetics Service, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia.
  • Emery T; South Australian Tissue Typing and Immunogenetics Service, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia.
  • Munasinghe W; South Australian Tissue Typing and Immunogenetics Service, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia.
  • Tsiopelas E; South Australian Tissue Typing and Immunogenetics Service, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia.
  • Fleet A; South Australian Tissue Typing and Immunogenetics Service, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia.
  • Lake M; South Australian Tissue Typing and Immunogenetics Service, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia.
  • Humphreys I; South Australian Tissue Typing and Immunogenetics Service, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia.
  • Jalalonmuhali M; Central Northern Adelaide Renal and Transplantation Services (CNARTS), Royal Adelaide Hospital, Adelaide, South Australia, Australia; Department of Medicine, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  • Coates P; South Australian Tissue Typing and Immunogenetics Service, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia; Central Northern Adelaide Renal and Transplantation Services (CNARTS), Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Hum Immunol ; 80(8): 573-578, 2019 Aug.
Article en En | MEDLINE | ID: mdl-31014826

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Intercambio Plasmático / Autoanticuerpos / Tetrazoles / Bencimidazoles / Receptores de Angiotensina / Trasplante de Riñón / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Rechazo de Injerto Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Hum Immunol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Intercambio Plasmático / Autoanticuerpos / Tetrazoles / Bencimidazoles / Receptores de Angiotensina / Trasplante de Riñón / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Rechazo de Injerto Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Hum Immunol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos